Puma Biotechnology
PBYI
PBYI
119 hedge funds and large institutions have $319M invested in Puma Biotechnology in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.84% less ownership
Funds ownership: 90.97% → 86.12% (-4.8%)
10% less capital invested
Capital invested by funds: $356M → $319M (-$36.6M)
Holders
119
Holding in Top 10
–
Calls
$1.13M
Puts
$696K
Top Buyers
| 1 | +$1.65M | |
| 2 | +$1.56M | |
| 3 | +$1.38M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.3M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$1.17M |
Top Sellers
| 1 | -$7.29M | |
| 2 | -$5.88M | |
| 3 | -$4.03M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$3.35M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.22M |